摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-甲氧基苯基)-3,6-二甲基-3,4-二氢-1H-吡啶-2-酮 | 89733-53-9

中文名称
5-(4-甲氧基苯基)-3,6-二甲基-3,4-二氢-1H-吡啶-2-酮
中文别名
——
英文名称
3,6-Dimethyl-5-(4-methoxyphenyl)-2-oxo-1,2,3,4-tetrahydropyridine
英文别名
3,4-dihydro-5-(4-methoxyphenyl)-3,6-dimethyl-2(1H)-pyridinone;3,6-dimethyl-5-(4-methoxyphenyl)-3,4-dihydro-2-pyridone;5-(4-Methoxyphenyl)-3,6-dimethyl-3,4-dihydropyridin-2(1H)-one;5-(4-methoxyphenyl)-3,6-dimethyl-3,4-dihydro-1H-pyridin-2-one
5-(4-甲氧基苯基)-3,6-二甲基-3,4-二氢-1H-吡啶-2-酮化学式
CAS
89733-53-9
化学式
C14H17NO2
mdl
——
分子量
231.294
InChiKey
IHMHSIAZMZWAFZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:260d89b66d2b8a4a812eaf8f6a3ac974
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 2-Pyridinones and their use as cardiotonic agents
    申请人:Sterling Drug Inc.
    公开号:US04431651A1
    公开(公告)日:1984-02-14
    3,4-Dihydro-3-R.sub.1 -4-R.sub.2 -5-Q-6-R-2(1H)-pyridinones (I), where R.sub.1 and R.sub.2 are each hydrogen or methyl, R is lower-alkyl, and Q is 4(or 3)-hydroxyphenyl, 4(or 3)-methoxyphenyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents, or acid-addition salts thereof, and their preparation are shown. Also shown is the cardiotonic use of I where Q is 4(or 3)-hydroxyphenyl, 4(or 3)-pyridinyl or 4(or 3)-pyridinyl having one or two lower-alkyl substituents.
    3,4-二氢-3-R.sub.1-4-R.sub.2-5-Q-6-R-2(1H)-吡啶酮(I),其中R.sub.1和R.sub.2分别为氢或甲基,R为低碳烷基,Q为4(或3)-羟基苯基、4(或3)-甲氧基苯基、4(或3)-吡啶基或带有一个或两个低碳烷基取代基的4(或3)-吡啶基,或其酸盐,以及它们的制备。还显示了I的强心用途,其中Q为4(或3)-羟基苯基、4(或3)-吡啶基或带有一个或两个低碳烷基取代基的4(或3)-吡啶基。
  • Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having
    申请人:Duphar International Research B.V.
    公开号:US05091393A1
    公开(公告)日:1992-02-25
    The invention relates to a group of tertiary 2,5-dialkyl-3-phenylpiperidine derivatives, having opiate-antagonistic activity represented by general formula 4, ##STR1## wherein A.sub.1 is hydrogen, an optionally esterified hydroxyl group or mercapto group, a group NHA.sub.8 or --CONHA.sub.8, wherein A.sub.8 is hydrogen, alkyl having 1-6 C-atoms or alkylcarbonyl having 2-7 C-atoms; A.sub.2 is hydrogen or, when A.sub.1 is hydrogen, one of the other meanings of A.sub.1, or A.sub.1 and A.sub.2 together with the 2 carbon atoms of the benzene ring,constitute a heterocyclic group which consists of five or six ring atoms and which comprises a group --NH-- and optionally as a second hetero atom may comprise an oxygen atom, sulphur atom or nitrogen atom; A.sub.3 and A.sub.4 independently of each other are straight or branched alkyl or alkenyl having 1-6 C-atoms; A.sub.5 is a straight or branched alkylene chain having 2-8 C-atoms; X is the carbonyl group or ketalized carbonyl group or the group>CHOH, --CONH--, --NHCO--, methylene, >CHC.sub.6 H.sub.5, or an oxygen atom or sulphur atom; A.sub.6 is an alkyl group, cycloalkyl group or cycloalkylalkyl group having at most 10 C-atoms and optionally substituted with one or more groups A.sub.7, or is a phenyl group or phenylalkyl group having 1-4 C-atoms in the alkyl group and optionally substituted with one or more groups A.sub.7, and A.sub.7 is alkyl, alkoxy or alkylthio having 1-4 C-atoms, amino, mono- or dialkylamino having 1-4 C-atoms per alkyl group, hydroxyalkyl, alkylcarbonyl, alkylaminocarbonyl or alkoxycarbonyl having 1-4 C-atoms in the alkyl group, nitro, cyano, halogen, trifluoromethyl, trifluoromethoxy, alkylsulphonyl having 1-4 C-atoms, or aminosulphonyl. These compounds have a pure opiate-antagonistic activity, i.e. without an agonistic activity component.
    本发明涉及一类三级2,5-二烷基-3-苯基哌啶生物,其具有通过通式4表示的阿片拮抗活性,其中A.sub.1是氢、一个可选酯化的羟基或巯基、一个NHA.sub.8或--CONHA.sub.8基团,其中A.sub.8是氢、具有1-6个碳原子的烷基或具有2-7个碳原子的烷基酰基;A.sub.2是氢或者当A.sub.1是氢时,A.sub.1的其他含义之一,或者A.sub.1和A.sub.2与苯环的2个碳原子一起构成一个由五个或六个环原子组成的杂环基团,其中包括一个--NH--基团,可选地,作为第二个杂原子,可以包括一个氧原子、原子或氮原子;A.sub.3和A.sub.4独立地是直链或支链烷基或烯基,具有1-6个碳原子;A.sub.5是具有2-8个碳原子的直链或支链烷基链;X是羰基或缩醛羰基或基团>CHOH、--CONH--、--NHCO--、亚甲基、>CHC.sub.6 H.sub.5、或氧原子或原子;A.sub.6是具有最多10个碳原子的烷基、环烷基或环烷基烷基,可选地取代一个或多个基团A.sub.7,或者是具有1-4个碳原子的烷基取代的苯基或苯基烷基,可选地取代一个或多个基团A.sub.7,A.sub.7是具有1-4个碳原子的烷基、烷氧基或烷基、基、1-4个碳原子的烷基组成的单烷基或双烷基基、羟基烷基、烷基羰基、烷基基羰基或烷氧基羰基,具有1-4个碳原子的硝基、基、卤素、三甲基、三甲氧基、具有1-4个碳原子的烷基磺酰基或基磺酰基。这些化合物具有纯阿片拮抗活性,即没有激动活性成分。
  • 2(1H)-pyridinones and preparation, useful as cardiotonics
    申请人:STERLING DRUG INC.
    公开号:EP0109628A1
    公开(公告)日:1984-05-30
    3,4-Dihydro-3-R1-4-R2-5-Q-6-R-2 (1H)-pyridinones (I), where R1 and R2 are each hydrogen or methyl, R is lower-alkyl, and Q is 4 (or 3)-hydroxyphenyl, 4 (or 3)-methoxyphenyl, 4 (or 3)-pyridinyl or 4 (or 3)-pyridinyl having one or two lower-alkyl substituents, or acid-addition salts thereof, as well as the corresponding 3-R1-4-R2-5-Q-6-R-2 (1H)-pyridinones where at least one of R1 and R2 is methyl. The compounds have cardiotonic use when Q is 4 (or 3)-hydroxyphenyl, 4 (or 3)-pyridinyl or 4 (or 3)-pyridinyl having one or two lower-alkyl substituents. Said compounds are prepared from butanenitriles, butanoates, acrylamides or mixtures of alkanones and acetoacetamide, with optional conversion of the 3,4-dihydro compounds obtained to the 3,4-unsaturated compounds by heating with sulfur in an inert solvent and conversion of the methoxyphenyl compounds to the hydroxyphenyl compounds.
    3,4-二氢-3-R1-4-R2-5-Q-6-R-2 (1H)-吡啶酮 (I),其中 R1 和 R2 分别为氢或甲基,R 为低级烷基,Q 为 4(或 3)-羟基苯基、4(或 3)-甲氧基苯基、4(或 3)-吡啶基或具有一个或两个低级烷基取代基的 4(或 3)-吡啶基,或其酸加成盐、4(或 3)-吡啶基或具有一个或两个低级烷基取代基的 4(或 3)-吡啶基,或其酸加成盐,以及相应的 3-R1-4-R2-5-Q-6-R-2 (1H)-pyridinones (其中 R1 和 R2 中至少有一个是甲基)。当 Q 为 4(或 3)-羟基苯基、4(或 3)-吡啶基或具有一个或两个低级烷基取代基的 4(或 3)-吡啶基时,这些化合物具有强心作用。上述化合物由丁烯腈、丁酸盐、丙烯酰胺或烷酮和乙酰乙酰胺的混合物制备,可选择在惰性溶剂中用加热,将得到的 3,4-二氢化物转化为 3,4-不饱和化合物,并将甲氧基苯基化合物转化为羟基苯基化合物。
  • Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
    申请人:DUPHAR INTERNATIONAL RESEARCH B.V
    公开号:EP0299549A2
    公开(公告)日:1989-01-18
    The invention relates to a group of tertiary 2,5-dialkyl-3-phenylpiperidine derivatives, having opiate-antagonistic activity represented by general formula 4, wherein S1 is hydrogen, an optionally esterified hydroxyl group or mercapto group, a group -NHS8 or -CONHS8, wherein S8 is hydrogen, alkyl having 1-6 C-atoms or alkylcarbonyl having 2-7 C-atoms; S2 is hydrogen or, when S1 is hydrogen, one of the other meanings of Si, or S1 and S2 together with the 2 carbon atoms of the benzene ring, constitute a heterocyclic group which consists of five or six ring atoms and which comprises a group -NH-and optionally as a second hetero atom may comprise an oxygen atom, sulphur atom or nitrogen atom; S3 and S4 independently of each other are straight or branched alkyl or alkenyl having 1-6 C-atoms; Ss is a straight or branched alkylene chain having 2-8 C-atoms; X is the carbonyl group or ketalised carbonyl group or the group CHOH, -CONH-, -NHCO-, methylene, CHC6H5 or an oxygen atom or sulphur atom; S6 is an alkyl group, cycloalkyl group or cycloalkylalkyl group having at most 10 C-atoms and optionally substituted with one or more groups 87, or is a phenyl group or phenylalkyl group having 1-4 C-atoms in the alkyl group and optionally substituted with one or more groups S7. and S7 is alkyl, alkoxy or alkylthio having 1-4 C-atoms, amino, mono- or dialkylamino having 1-4 C-atoms per alkyl group, hydroxyalkyl, alkylcarbonyl , alkylaminocarbonyl or alkoxycarbonyl having 1-4 C-atoms in the alkyl group, nitro, cyano, halogen, trifluoromethyl, trifluoromethoxy, alkylsulphonyl having 1-4 C-atoms, or aminosuiphonyl. These compounds have a pure opiate-antagonistic activity, i.e. without an agonistic activity component.
    本发明涉及一组具有鸦片拮抗剂活性的 2,5-二烷基-3-苯基哌啶叔衍生物,由通式 4 表示、 其中 S1 是氢、任选酯化的羟基或巯基、基团 -NHS8 或 -CONHS8,其中 S8 是氢、具有 1-6 个 C 原子的烷基或具有 2-7 个 C 原子的烷基羰基; S2 是氢,或当 S1 是氢时,是 Si 的其他含义之一,或 S1 和 S2 与苯环上的 2 个碳原子一起构成一个杂环基团,该杂环基团由 5 个或 6 个环原子组成,其中包含一个基团-NH,作为第二个杂原子可选择包含一个氧原子、原子或氮原子; S3 和 S4 相互独立地为具有 1-6 个 C 原子的直链或支链烷基或烯基; Ss 是具有 2-8 个 C 原子的直链或支链亚烷基; X 是羰基或酮化羰基或 CHOH、-CONH-、-NHCO-、亚甲基、CHC6H5 或氧原子或原子; S6 是最多具有 10 个 C 原子并可选择被一个或多个基团 87 取代的烷基、环烷基或环烷基烷基,或 是烷基中具有 1-4 个 C 原子并可选择被一个或多个基团 S7 取代的苯基或苯基烷基。 S7 是烷基、烷氧基或具有 1-4 个 C 原子的烷基、基、每个烷基具有 1-4 个 C 原子的单烷基或二烷基基、羟基烷基、烷基羰基、烷基基羰基或烷氧基羰基、硝基、基、卤素、三甲基、三甲氧基、具有 1-4 个 C 原子的烷基磺酰基或杨基。 这些化合物具有纯粹的阿片拮抗活性,即不含激动活性成分。
  • SINGH, B., SYNTHESIS, BRD, 1985, N 3, 305-306
    作者:SINGH, B.
    DOI:——
    日期:——
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯